tirzepatide and fibroids 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — a rare, painful, often Tirzepatide, Uterine Fibroids, and Adenomyosis

Acetylcarnitine, which, as we have described, plays an important role in mitochondrial energy metabolism, is an FDA-approved dietary supplement that has been studied for the treatment of fatigue in aging, cancer, chronic hepatitis, ME/CFS, MS, and MDD

Practices such as mindfulness, meditation, deep breathing exercises, and progressive muscle relaxation can help reduce stress levels

Niso-Santano, M

1 AEs leading to treatment discontinuation occurred in 6.7% of patients in the semaglutide group and 3.0% of patients in the placebo group

however, in a meta-analysis of cohort studies comparing glargine to NPH, maternal and fetal outcomes were similar (142) and no adverse maternal or fetal effects have been described to date